Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Professor, Jur. Dr., LL.M., M.I.C.L.

Karen Blixens Plads 16

Copenhagen, 2300

Denmark

http://jura.ku.dk/cebil/staff/profile/?pure=en/persons/381631

SCHOLARLY PAPERS

53

DOWNLOADS
Rank 8,430

SSRN RANKINGS

Top 8,430

in Total Papers Downloads

5,339

CITATIONS

6

Scholarly Papers (53)

1.

Res Judicata in the ECJ Case Law: Balancing Legal Certainty with Legality?

European Constitutional Law Review, Issue 3, pp. 385-417, 2007
Number of pages: 33 Posted: 06 Oct 2009 Last Revised: 02 Sep 2015
Xavier Groussot and Timo Minssen
Lund University - Faculty of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 772 (31,009)

Abstract:

Loading...

Res Judicata, European Court of Justice, Legal Certainty, Legality, Revision of Decisions, State Liability, Acte Clair; Kühne & Heitz, Köbler

2.

The Rule of Reason under Article 82 EC after Sot Lelos Kai Sia

Number of pages: 29 Posted: 07 Jul 2009 Last Revised: 02 Sep 2015
Tu T. Nguyen, Timo Minssen and Xavier Groussot
Faculty of Law, Lund University, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University - Faculty of Law
Downloads 605 (43,082)
Citation 1

Abstract:

Loading...

rule of reason, refusal to supply, parallel trade, pharmaceutical sector, Article 82 EC

3.

The Evolution of the CJEU's Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.

Published in Nordic Intellectual Property Law Review (NIR), Nr. 5, pp. 493-503 (2015).
Number of pages: 10 Posted: 13 Mar 2015 Last Revised: 25 Feb 2016
Timo Minssen and Ana Nordberg
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University - Faculty of Law
Downloads 596 (43,969)

Abstract:

Loading...

biotech, patents, Europe, stem cells, innovation policy

4.

The Impact of Broccoli II & Tomato II on European Patents in Conventional Breeding, GMO's and Synthetic Biology: The Grand Finale of a Juicy Patents Tale?

Biotechnology Law Report, Vol. 34, No. 3 (2015), pp. 81-98
Number of pages: 24 Posted: 19 May 2015 Last Revised: 30 Jul 2017
Timo Minssen and Ana Nordberg
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University - Faculty of Law
Downloads 576 (45,964)

Abstract:

Loading...

Biotechnology, Patents, Plant Science, European Patent Office, GMOs, Synthetic Biology, Conventional breeding methods, essentially biological processes, agricultural industry, CRISPR, unitary patent

5.

Legal Aspects of Biobanking as Key Issues for Personalized Medicine & Translational Exploitation

Personalized Medicine, Vol. 11, No. 5, Pages 497-508
Number of pages: 16 Posted: 18 Jan 2014 Last Revised: 31 Dec 2014
Timo Minssen and Jens Schovsbo
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Centre for Information and Innovation Law (CIIR)
Downloads 354 (83,283)

Abstract:

Loading...

biobanks, law & ethics, intellectual property, informed consent, personalized medicine, open innovation, translational medicine

6.

US Patent Eligibility in the Wake of Bilski v. Kappos: 'Business as Usual' in an Age of New Technologies?

Biotechnology Law Report, Vol. 30, Nr. 1, 2011, pp. 3-56, including a sequel at pp. 57-58.
Number of pages: 77 Posted: 26 Sep 2010 Last Revised: 01 Nov 2015
Timo Minssen and Robert M. Schwartz
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University Faculty of Law
Downloads 345 (85,820)

Abstract:

Loading...

7.

Patenting Bioprinting-Technologies in the US and Europe – The 5th Element in the 3rd Dimension

“Patenting Bioprinting Technologies in the US and Europe– The 5th element in the 3rd dimension", Working Paper, prepared for Ch. 7 in: RM Ballardini, M Norrgård & J Partanen (red), 3D printing, Intellectual Property & Innovation – Insights from Law & Technology. Wolters Kluwer (2017 Forthcoming).
Number of pages: 27 Posted: 08 Apr 2017 Last Revised: 23 Oct 2017
Timo Minssen and Marc Mimler
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Bournemouth University - Centre for Intellectual Property Policy & Management (CIPPM)
Downloads 297 (101,221)

Abstract:

Loading...

8.

Meanwhile on the Other Side of the Pond: Why Biopharmaceutical Inventions that Were 'Obvious to Try' Still Might Be Non-Obvious – Part I

Chicago-Kent Journal of Intellectual Property, Vol. 9, Spring 2010
Number of pages: 72 Posted: 27 Sep 2009 Last Revised: 02 Sep 2015
Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 233 (130,361)

Abstract:

Loading...

DNA-related inventions, patentability, inventive step, non-obviousness, obvious to try, biopharmaceutical industry, US, Europe

9.

Standardization, IPRs and Open Innovation in Synthetic Biology

Contribution to article compilation "Innovation, Competition, Collaboration" based on 2013 conference at Bucerius Law School, Hamburg, Germany
Number of pages: 20 Posted: 16 Feb 2014 Last Revised: 02 Sep 2015
Timo Minssen and Jakob Wested
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Centre for Advanced Studies in Biomedical Innovation Law (CeBIL)
Downloads 231 (131,457)

Abstract:

Loading...

standardization, open innovation, synthetic biology, intellectual property rights

10.

The Industrial Application Requirement for Biotech Inventions in Light of Recent EPO & UK Case Law: A Plausible Approach or a Mere 'Hunting License'?

E.I.P.R. , Vol 34, Nr. 10, S. 689-703 (2012)
Number of pages: 23 Posted: 11 Sep 2014
Timo Minssen and David Nilsson
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Independent
Downloads 225 (134,881)

Abstract:

Loading...

11.

A Review of 'Patents and Technological Progress in a Globalized World - Liber Amicorum Joseph Straus'

The IP Law Book Review, Vol. 2, Issue 2, January 2012
Number of pages: 12 Posted: 01 Sep 2011 Last Revised: 02 Sep 2015
Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 161 (182,984)

Abstract:

Loading...

Patents, Pharmaceuticals, Biotechnology, IPR

12.

Patenting Human Genes in Europe - And How It Compares to the US and Australia

Research Handbook on Intellectual Property and the Life Sciences (eds. Herbert Zech & Duncan Matthews), Chapter 1.5, Edward Elgar, 2016
Number of pages: 13 Posted: 27 Feb 2016 Last Revised: 29 Jul 2019
Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 156 (187,969)

Abstract:

Loading...

Patents, DNA, Europe, Genes

13.

Restoring the Balance: The Patentability of DNA-Related Technology in the US and Europe

Number of pages: 10 Posted: 07 Oct 2009 Last Revised: 02 Sep 2015
Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 147 (197,447)

Abstract:

Loading...

patent law, private law, comparative law, intellectual property law, patents, innovation system, biotechnology, DNA, proteins

14.

Book Review: Pharmaceutical Innovation, Competition and Patent Law – A Trilateral Perspective

Forthcoming in European Competition Law Review (E.C.L.R.). Issue 4, pp. 151-155 (Sweet & Maxwell 2014).
Number of pages: 6 Posted: 17 Feb 2014 Last Revised: 19 Feb 2014
Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 121 (230,219)

Abstract:

Loading...

Pharmaceutical law, Health law, Competition law, Innovation

15.

The 'Opt Out' and 'Opt-In' Provisions in the Unified Patent Court Agreement -- Impact and Strategies for European Patent Portfolios

Nordic Intellectual Property Law Review (NIR), Issue 4, pp 340-357 (2014)., University of Copenhagen Faculty of Law Research Paper No. 2015-3
Number of pages: 18 Posted: 22 Apr 2015 Last Revised: 08 Jul 2016
Timo Minssen and Bjorn Lundqvist
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Stockholm University - Faculty of Law
Downloads 117 (236,013)

Abstract:

Loading...

Unitary patent, IPR, strategies, patent portfolios

16.

Clinical Trial Data Transparency and GDPR Compliance: Implications for Data Sharing and Open Innovation

In: Katerina Sideri & Graham Dutfield (eds.), Openness, Intellectual Property and Science Policy in the Age of Data Driven Medicine, Special Issue of Science and Public Policy (2019 Forthcoming)
Number of pages: 19 Posted: 02 Jul 2019 Last Revised: 19 Jul 2019
Timo Minssen, Rajam N. and Marcel Bogers
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen and University of Copenhagen - Department of Food and Resource Economics (IFRO)
Downloads 85 (292,375)

Abstract:

Loading...

17.

TRIPS and the Life Sciences - Perspectives on Limitations to Patentability

University of Copenhagen Faculty of Law Research Paper No. 2017-37
Number of pages: 9 Posted: 16 Jun 2017 Last Revised: 08 Jul 2017
Jakob Wested and Timo Minssen
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 63 (346,009)

Abstract:

Loading...

TRIPS agreement, Patents, Correa guidelines, Technological neutrality, non-discrimination, Life science, Pharmaindustry, Biotechnology

18.

The US Examination of Nonobviousness after KSR vs. Teleflex with Special Emphasis on DNA-Related Inventions

IIC, Vol. 39, No. 8, pp. 886-916, 2008
Number of pages: 32 Posted: 13 Dec 2009 Last Revised: 02 Sep 2015
Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 58 (360,445)

Abstract:

Loading...

KSR v. Telefex, Ex parte Kubin, nonobviousness, DNA-related inventions

19.

AIRR Data Under the E.U. Trade Secrets Directive: Aligning Scientific Practices with Commercial Realities

The Harmonization and Protection of Trade Secrets in the E.U. (Jens Schovsbo, Timo Minssen & Thomas Riis eds.) (Edward Elgar, 2019 Forthcoming), NYLS Legal Studies Research Paper No. 3249498
Number of pages: 23 Posted: 23 Oct 2018
Jacob S. Sherkow and Timo Minssen
New York Law School and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 55 (369,813)

Abstract:

Loading...

AIRR, immune receptor, antibodies, TCRs, EU, trade secrets, science, genetic data, big data, follow-on data, patents, clinical trials, diagnostics

20.

Research and Bolar Exemptions in the U.S. and Europe: Recent Developments and Possible Scenarios

Number of pages: 11 Posted: 30 Aug 2018
Jakob Wested and Timo Minssen
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 41 (418,011)

Abstract:

Loading...

LIfe Science, Bolar Provision, Research Exemption, Patent, TRIPS Agreement

21.

Rules and Tools in the Battle Against Superbugs - A Call for Integrated Strategies and Enhanced International Collaboration to Promote Antimicrobial Drug Development

Forthcoming in Infectious Diseases in the New Millennium: Legal and Ethical Challenges, Mark Eccleston-Turner (ed) (Springer, 2019)., University of Copenhagen Faculty of Law Research Paper No. 2018-58
Number of pages: 23 Posted: 02 May 2018 Last Revised: 17 Jul 2019
Timo Minssen and Ana Nordberg
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University - Faculty of Law
Downloads 39 (425,830)

Abstract:

Loading...

Sustainable Incentives, Regulation, IPRs, Antimicrobials, Antibiotics, AM Resistance

22.

Procedural Aspects of Compulsory Licensing Under TRIPS: Report No. II of Webinar Series on Reinterpreting TRIPS in the Life Sciences

Number of pages: 9 Posted: 28 Sep 2017
Jakob Wested and Timo Minssen
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law
Downloads 34 (446,408)

Abstract:

Loading...

TRIPS, Life Science, Patents, Compulsory Licensing, Access to Medicine, NATCO

23.

Separating Sheep from Goats: A European View on the Patent Eligibility of Biomedical Diagnostic Methods

Journal of Law and the Biosciences, Vol. 3, No. 2, pp. 365-372 (2016)
Number of pages: 9 Posted: 27 Jun 2019
Timo Minssen and Robert M. Schwartz
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University Faculty of Law
Downloads 28 (474,379)

Abstract:

Loading...

24.

Standards, Data Exchange and Intellectual Property Rights in Systems Biology

Biotechnology Journal, Vol. 11, No.12, pp. 1477-1480
Posted: 30 Jun 2019
University of Leuven, European Patent Office and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

25.

Standing on Shaky Ground- US Patent-Eligibility of Isolated DNA and Genetic Diagnostics after AMP v. USPTO – Part III (Unsolved Questions & Subsequent Case Law)

Queen Mary Journal of Intellectual Property, Vol. 2, No. 3, pp.225-249 (2012)
Posted: 27 Jun 2019
Timo Minssen and David Nilsson
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Independent

Abstract:

Loading...

26.

Standing on Shaky Ground- US Patent-Eligibility of Isolated DNA and Genetic Diagnostics after Amp v. Uspto – Part II (Practical Implications & Chances for Supreme Court Review)

Queen Mary Journal of Intellectual Property, Vol. 2, No. 2, pp.136-157 (2012)
Posted: 27 Jun 2019
Timo Minssen and David Nilsson
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Independent

Abstract:

Loading...

27.

Reconciling IPRs and Openness in Biobanking

European Intellectual Property Review, Vol. 38, No. 1, pp. 1-4, 2016
Posted: 27 Jun 2019
Michiel Verlinden, Timo Minssen and Isabelle Huys
Research Centre for Pharmaceutical Care and Pharmaco-economics, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and affiliation not provided to SSRN

Abstract:

Loading...

28.

IPRs in Biobanking - Risks and Opportunities for Translational Research

Intellectual Property Quarterly, Vol. 2015, No.2, pp.106-129
Posted: 27 Jun 2019
Timo Minssen, Michiel Verlinden and Isabelle Huys
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Research Centre for Pharmaceutical Care and Pharmaco-economics and affiliation not provided to SSRN

Abstract:

Loading...

29.

Myriad Reloaded and Ready for the Next Round?

Queen Mary Journal of Intellectual Property, Vol.3, No.1, pp. 70-80 (2013)
Posted: 27 Jun 2019
Timo Minssen and Robert M. Schwartz
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University Faculty of Law

Abstract:

Loading...

30.

The US Supreme Court in Mayo v. Prometheus - Taking the Fire from or to Biotechnology and Personalized Medicine? Supreme Court of the United States, Mayo Collaborative Services, dba Mayo Medical Laboratories, et al., Petitioners v Prometheus Laboratories, Inc ., 132 S.Ct. 1289

Queen Mary Journal of Intellectual Property, Vol. 2, No. 4, pp.376-388 (2012)
Posted: 27 Jun 2019
Timo Minssen and David Nilsson
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Independent

Abstract:

Loading...

31.

US Declatory Judgment Jurisdiction and the U.S. Supreme Court Decision InMedImmune (Zur Zulässigkeit von Feststellungsklagen im US Lizensrecht nach den Entscheidungen in MedImmune und SanDisk)

Gewerblicher Rechtsschutz und Urheberrecht. Internationaler Teil, Vol. 57, No.3, pp. 192-200, 2008
Posted: 27 Jun 2019
Timo Minssen and Gösta Schindler
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and affiliation not provided to SSRN

Abstract:

Loading...

32.

Much Ado About Something: Legal, Ethical and Scientific Challenges in International Biobanking and Translational Exploitation

Global Genes, Local Concerns- Legal, Ethical and Scientific Challenges in International Biobanking.. ed. / Timo Minssen; Janne Rothmar Herrmann; Jens Schovsbo. Edward Elgar Publishing, 2019. ISBN 9781788116183
Posted: 26 Apr 2019
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen - Faculty of Law and Centre for Information and Innovation Law (CIIR)

Abstract:

Loading...

33.

Clinical Trials Data Transparency & GDPR Compliance: What Are the Effects on Data Sharing and Open Innovation?

In : Katerina Sideri & Graham Dutfield (eds.), Openness, Intellectual Property and Science Policy in the Age of Data Driven Medicine, Special Issue of Science and Public Policy (2019)
Posted: 25 Apr 2019 Last Revised: 18 Jul 2019
Timo Minssen, Rajam N. and Marcel Bogers
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen and University of Copenhagen - Department of Food and Resource Economics (IFRO)

Abstract:

Loading...

34.

Shadow Health Records Meet New Data Privacy Laws

Science, Vol. 363, No. 6426, 01.02.2019, p. 448-450., U of Colorado Law Legal Studies Research Paper No. 19-13
Posted: 25 Apr 2019 Last Revised: 03 May 2019
University of Michigan Law School, University of Michigan at Ann Arbor - Medical School, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Colorado Law School

Abstract:

Loading...

35.

What Lurks in the Shadows of the Openness Hyperbole for Biopharmaceuticals?

Drug Development Research, 11.03.2019.
Posted: 25 Apr 2019 Last Revised: 30 Jun 2019
Rajam N. and Timo Minssen
University of Copenhagen and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

36.

An Update on Research- & Bolar Exemptions in the U.S. and Europe: Unsolved Questions and New Developments in an Increasingly Important Area of Law

NIR: Nordiskt Immateriellt Rättsskydd, Vol. 2019, No. 2, pp. 168-183
Posted: 25 Apr 2019 Last Revised: 26 Jun 2019
Jakob Wested and Timo Minssen
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

An 'Export-Only' Exception to Pharmaceutical Patents in Europe: Should the U.S. Follow Suit?

Nature Biotechnology, Vol. 37, No. 1, 03.01.2019, p. 21-22.
Posted: 24 Apr 2019
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Brigham and Women's Hospital/Harvard Medical School and Harvard Medical School

Abstract:

Loading...

An 'Export-Only' Exception to Pharmaceutical Patents in Europe: Should the U.S. Follow Suit?

Nature Biotechnology, Vol.37, No. 1, pp. 21-22 (2019); DOI: 10.1038/nbt.4324
Posted: 27 Jun 2019
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Brigham and Women's Hospital/Harvard Medical School and Harvard Medical School

Abstract:

Loading...

38.

Will the EPO’s Enlarged Board Hear the Broad’s CRISPR Case?

Life Sciences Intellectual Property Review (LSIPR), No. 13/7 2018, 13.07.2018.
Posted: 24 Apr 2019
Jakob Wested, Timo Minssen and Esther van Zimmeren
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Leuven

Abstract:

Loading...

39.

Reap What You Sow! — But What About SPC Squatting?

Journal of Intellectual Property Law & Practice, Vol. 13, No. 7, 2018, p. 569-580.
Posted: 24 Apr 2019
Centre for Information and Innovation Law (CIIR), University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Inspicos P/S

Abstract:

Loading...

40.

Unlocking the Full Potential of Open Innovation in the Life Sciences Through a Classification System

Drug Discovery Today, Vol. 23, No. 4, 01.04.2018, p. 771-775.
Posted: 24 Apr 2019
Niclas Nilsson and Timo Minssen
affiliation not provided to SSRN and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

41.

Clearing a Way Through the CRISPR Patent Jungle

Life Sciences Intellectual Property Review (LSIPR), No. 8/5 2018, 2018.
Posted: 24 Apr 2019
Timo Minssen, Esther van Zimmeren and Jakob Wested
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Leuven and Centre for Advanced Studies in Biomedical Innovation Law (CeBIL)

Abstract:

Loading...

42.

Big Data and Intellectual Property Rights in the Health and Life Sciences

Cambridge University Press, Big Data, Health Law, and Bioethics, 2018. p. 311-323.
Posted: 24 Apr 2019
Timo Minssen and Justin Pierce
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University - Faculty of Law

Abstract:

Loading...

43.

A Ray of Light in Muddy Waters? -The CJEU Rules on Combination SPCs in C-121/17 Teva v Gilead

European Pharmaceutical Law Review, Vol. 2, No. 3, 2018, p. 169-173.
Posted: 24 Apr 2019
Timo Minssen and Sven Bostyn
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Liverpool - School of Law & Social Justice

Abstract:

Loading...

44.

Editing Humanity?: An Interdisciplinary Commentary on Genome Editing in Assisted Reproductive Technology

Posted: 10 Dec 2018
Lund University - Faculty of Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Centre of Bioethical Research and Analysis (COBRA), National University of Ireland (Galway), Rep. of Ireland, Independent, Independent and Independent

Abstract:

Loading...

Assisted Reprudution Technology, Gene Editing & Law, Human Enhancement, Bioethics & Law, Bioethics & Genetics, Techn Regulation

45.

How Much Is Too Much?: Defining the Metes and Bounds of Excessive Pricing in the Pharmaceutical Sector

Posted: 16 Nov 2018
Behrang Kianzad and Timo Minssen
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

Excessive Prices, Excessive Pricing, Pharmaceutical Pricing, Competition Law, Intellectual Property Law, Patent Law, European Patent Law, Article 102, TRIPS

Challenges for the Sustainability of University-Run Biobanks

Biopreservation and Biobanking, Vol. 16, No. 4, 08.2018, p. 312-321.
Posted: 25 Apr 2019
University of Copenhagen, University of Copenhagen - Faculty of Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen and Centre for Information and Innovation Law (CIIR)

Abstract:

Loading...

47.

Patentability Standards for Follow-On Pharmaceutical Innovation

37 BIOTECHNOLOGY LAW REPORT 131 (2018)
Posted: 31 Jul 2018
University of Missouri - Kansas City School of Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Sidley Austin LLP

Abstract:

Loading...

UNDP, Patentability Guidelines, Patent Examination, Pharmaceutical Patents, TRIPS Agreement

48.

Cutting Edges and Weaving Threads in the Gene Editing (Я)Evolution: Reconciling Scientific Progress with Legal, Ethical, & Social Concerns

Posted: 14 Sep 2017
Lund University - Faculty of Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen - Department of Media, Cognition and Communication, University of Copenhagen - Department of Media, Cognition and Communication, Niels Bohr Institute, University of Copenhagen and University of Copenhagen - Centre for Synthetic Biology

Abstract:

Loading...

Gene editing; Gene Drive; CRISPR/Cas9; Patents; Regulation; Interdisciplinary perspectives; Ethical and social concerns; law and technology; ELSI

49.

Six Recommendations on 'Synthetic Biology & Intellectual Property Rights'

Posted: 27 Feb 2016
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, European Patent Office and University of Leuven

Abstract:

Loading...

50.

Enforcing Patents in the Era of 3D Printing

Journal of Intellectual Property Law & Practice, Vol. 10, No. 11:850-866 (2015)
Posted: 06 Dec 2015
University of Helsinki - IPR University Center, University of Helsinki and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

3D printing, patents, IPR, enforcement

51.

A ‘Ray of Hope’ for European Stem Cell Patents or ‘Out of the Smog into the Fog’?: An Analysis of Recent European Case Law and How It Compares to the US

IIC - International Review of Intellectual Property and Competition Law, 47(2), 138-177, Marh 2016, DOI: 10.1007/s40319-016-0449-x
Posted: 27 Nov 2015 Last Revised: 07 Mar 2016
Ana Nordberg and Timo Minssen
Lund University - Faculty of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

Stem cell patents, EU, US, Biotechnology Directive, technical expertise, general courts

52.

Life after Myriad: The Uncertain Future of Patenting Biomedical Innovation & Personalized Medicine in an International Context

Intellectual Property Quarterly, Vol. 2015, Nr. 3, 08.2015, s. 189-241.
Posted: 21 Jun 2015 Last Revised: 05 Dec 2015
Robert M. Schwartz and Timo Minssen
Lund University Faculty of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

Biotechnology, US, Europe, Australia, Comparative Law, DNA, Myriad, patent-eligibility, personalized medicine, genetic diagnostics, USPTO 2014 Guidelines, methods, innovation, Unified Patent Court

53.

Standing on Shaky Ground - US Patent-Eligibility of Isolated DNA and Genetic Diagnostics after AMP v. USPTO: Part I

Queen Mary Journal of Intellectual Property Law, Vol. 1, No. 3, 2011
Posted: 29 Sep 2011 Last Revised: 17 Dec 2015
Timo Minssen and David Nilsson
University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Independent

Abstract:

Loading...